furosemide has been researched along with lisinopril in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.00) | 18.7374 |
1990's | 4 (10.00) | 18.2507 |
2000's | 11 (27.50) | 29.6817 |
2010's | 18 (45.00) | 24.3611 |
2020's | 3 (7.50) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cooper, WD; Donohoe, JF; Doyle, GD; Laher, M | 1 |
Beermann, B | 1 |
Donohoe, JF; Doyle, GD; Kelly, J; Laher, MS | 1 |
Beermann, BA; Odlind, BG; Sjöström, PA | 1 |
Bakris, GL; Sadler, R; Slataper, R; Vicknair, N | 1 |
Ebihara, A; Fujimura, A; Ohashi, K; Shiga, T; Sudoh, T; Sunaga, K; Tateishi, T | 1 |
D'Hondt, A; Depierreux, M; Hanson, B; Lustman, F | 1 |
Ezan, E; Fraser, C; Junot, C; MacFadyen, R; Morton, JJ; Robson, J; Struthers, AD | 1 |
Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
Abe, H; Chin, W; Hashimoto, K; Hirooka, K; Irino, H; Koretsune, Y; Kusuoka, H; Yamamoto, H; Yasuoka, Y; Yoshimoto, S | 1 |
Braun, U; Poon, IO | 1 |
Bae, JH; Cho, JM; Jin, ES; Kim, CJ; Kim, MJ; Lee, SH; Moon, JY; Sohn, IS | 1 |
Edelstein, C; Smith, ML; Yalavarthy, R | 1 |
Altenberger, H; Finsterer, J; Stöllberger, C | 1 |
Parker, T | 1 |
Chedgy, F; Howlett, DC; Inglis, C | 1 |
Baggish, AL; Dec, GW; Fifer, MA; Hutter, AM; Kanayama, G; Pope, H; Rothman, RD; Weiner, RB | 1 |
Ahmad, T; Milano, CA; Patel, CB; Rogers, JG | 1 |
McCullough, LD; Rosario, M; Song, SX | 1 |
Gopalakrishnan, PP; Manov, A; Subramaniam, S; Wardi, M; White, J | 1 |
Carroll, C; Hassanin, A | 1 |
Sweetser, S | 1 |
Doshi, A; Harizi, R; Kate, Y; Pandey, D; Syed, MP | 1 |
Attakora, J; Donkoh, IE; Ephraim, RKD; Essuman, G; Okyere, I; Okyere, P; Serwaa, D | 1 |
Almaghaslah, D; Khaled, A; Makki, S; Nagib, R; Siddiqua, A | 1 |
2 review(s) available for furosemide and lisinopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Abdominal Wall Pain: A Common Clinical Problem.
Topics: Abdominal Pain; Abdominal Wall; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Gluconate; Diagnosis, Differential; Diuretics; Furosemide; Humans; Hyperkalemia; Infusions, Intravenous; Lisinopril; Male; Potassium; Renal Insufficiency, Chronic | 2019 |
4 trial(s) available for furosemide and lisinopril
Article | Year |
---|---|
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Lisinopril; Middle Aged; Prospective Studies; Renal Circulation | 1993 |
Influence of lisinopril on urinary electrolytes excretion after furosemide in healthy subjects.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Double-Blind Method; Drug Interactions; Electrolytes; Furosemide; Humans; Lisinopril; Male; Premedication; Renin | 1993 |
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal | 1999 |
Twice-daily administration of a long-acting angiotensin-converting enzyme inhibitor has greater effects on neurohumoral factors than a once-daily regimen in patients with chronic congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Administration Schedule; Electrocardiography; Female; Furosemide; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Norepinephrine; Renin-Angiotensin System | 2004 |
34 other study(ies) available for furosemide and lisinopril
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Lisinopril in hypertension associated with renal impairment.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Furosemide; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension, Renal; Kidney Diseases; Lisinopril; Male; Middle Aged | 1987 |
Pharmacokinetics of lisinopril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Drug Interactions; Enalapril; Food; Furosemide; Humans; Injections, Intravenous; Kidney; Lisinopril; Male; Middle Aged | 1988 |
Lisinopril in the treatment of hypertensive patients with renal impairment.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Enalapril; Female; Furosemide; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney Diseases; Lisinopril; Male; Middle Aged | 1988 |
Delayed tolerance to furosemide diuresis. Influence of angiotensin converting enzyme inhibition by lisinopril.
Topics: Adult; Diuresis; Dose-Response Relationship, Drug; Drug Tolerance; Enalapril; Furosemide; Humans; Kidney; Lisinopril; Male; Random Allocation; Renin-Angiotensin System; Urodynamics | 1988 |
Nephrotic syndrome after norfloxacin.
Topics: Aged; Amlodipine; Anti-Infective Agents; Antihypertensive Agents; Clonidine; Creatinine; Diuretics; Female; Furosemide; Humans; Indomethacin; Isosorbide Dinitrate; Lisinopril; Nephrotic Syndrome; Norfloxacin; Proteinuria; Urinary Tract Infections | 1996 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Drug Therapy; Female; Furosemide; Health Services for the Aged; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypotension, Orthostatic; Lisinopril; Male; Outpatients; Patient Selection; Prazosin; Prevalence; Retrospective Studies; Veterans | 2005 |
Bloodletting-induced cardiomyopathy: reversible cardiac hypertrophy in severe chronic anaemia from long-term bloodletting with cupping.
Topics: Aged; Anemia, Iron-Deficiency; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Iron Compounds; Lisinopril; Phlebotomy; Treatment Outcome; Ultrasonography | 2008 |
Acute kidney injury complicating minimal change disease: the case for careful use of diuretics and angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Furosemide; Glucocorticoids; Humans; Kidney; Lisinopril; Male; Middle Aged; Nephrosis, Lipoid; Prednisone; Renal Dialysis | 2007 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Echocardiography; Furosemide; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mosaicism; Phenotype; Propanolamines; Spironolactone; Turner Syndrome; Ventricular Dysfunction, Left | 2009 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine | 2009 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |
Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population.
Topics: Anabolic Agents; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Diagnosis, Differential; Diuretics; Echocardiography, Doppler; Furosemide; Humans; Lisinopril; Male; Middle Aged | 2011 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Furosemide; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Lisinopril; Male; Middle Aged; Milrinone; Propanolamines; Severity of Illness Index; Spironolactone | 2012 |
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furosemide; Humans; Hyperlipidemias; Hypertension; Hypothyroidism; Insulin; Lisinopril; Liver Cirrhosis; Low Back Pain; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Obesity; Osteoarthritis; Prednisone; Stroke; Thyroxine; Vasculitis, Central Nervous System | 2012 |
Chest pain · shortness of breath · fever and nausea · Dx?
Topics: Adult; Antihypertensive Agents; Chest Pain; Diagnosis, Differential; Diuretics; Electrocardiography; Fever; Furosemide; Humans; Lisinopril; Male; Metoprolol; Myocardial Infarction; Myocarditis; Stroke Volume; Systemic Inflammatory Response Syndrome; Treatment Outcome; Troponin I; West Nile Fever; West Nile virus | 2015 |
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillation; Bone Density Conservation Agents; Deprescriptions; Digoxin; Diltiazem; Diuretics; Drug Overdose; Factor Xa Inhibitors; Female; Furosemide; Heart Failure; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Lisinopril; Loratadine; Metoprolol; Polypharmacy; Pyrazoles; Pyridones; Ranitidine; Syncope | 2017 |
A rare case of biventricular non-compaction.
Topics: Cardiomyopathies; Carvedilol; Coronary Artery Disease; Dyspnea; Furosemide; Heart Failure; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2020 |
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.
Topics: Adult; Aspirin; Bisoprolol; Conservative Treatment; Furosemide; Ghana; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Metformin; Middle Aged; Nifedipine; Ranitidine; Renal Replacement Therapy; Retrospective Studies; Sodium | 2022 |
Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Enoxaparin; Furosemide; Humans; Lisinopril; Ranitidine; Tertiary Care Centers | 2023 |